Monoclonal antibodies provide protection against a wide range of infectious microbes, and now, in a series of elegant ...

Congenital adrenal hyperplasia (CAH) is a rare autosomal recessive disease1 with an estimated global incidence of approximately 1 in 14,000–18,000 live births2A phase II trial has recently been ...

WAYNE, PA — Aclaris Therapeutics, Inc. (NASDAQ: ACRS) has launched a Phase 1a/1b clinical program to evaluate the safety and ...

In a prostate cancer mouse model (22Rv1 xenografts), the combination of 225 Ac-YS5 (0.12 µCi) + YS5-MMAE (1.8 mg/kg) was associated with the most significant reduction in tumor volume (green curves in ...

Two new drugs for Alzheimer’s have been rejected for use on the NHS. They slow progression of the disease, but they can have ...

Phase 1 data for Spyre Therapeutics, Inc.'s SPY002 & SPY072 show promise in autoimmune treatments. Advancing to Phase 2 ...

The Food and Drug Administration (FDA) has granted Fast Track designation to TEV-53408, an investigational anti-interleukin-15 (IL-15) antibody, for the treatment of celiac disease.

She was enrolled in a clinical trial evaluating ivermectin (an anti-parasite drug with immune stimulatory activity) and balstilimab (an immunotherapy) with limited success. She is currently enrolled ...

Use of an immunomodulator the day before or day of treatment with infliximab was associated with a delay in development of anti-drug antibodies and undetectable drug concentrations compared to ...

Blocking an inflammatory molecule known as interleukin-11 (IL-11) extends the lifespan of mice, suggesting that drugs inhibiting IL-11 may have anti-ageing ... drug that uses antibodies to block ...

Bio-Rad Laboratories, Inc. (NYSE: BIO and BIO.B), launched four new anti-idiotypic antibodies to the following drugs: atezolizumab (Tecentriq), avelumab (Bavencio), obinutuzumab (Gazyvaro), and ...